ANEB logo

Anebulo Pharmaceuticals, Inc. Common Stock


ANEB: Anebulo Pharmaceuticals Inc is a clinical-stage biotechnology company. It is developing novel solutions for people suffering from cannabinoid overdose and substance addiction. The product candidate, ANEB-001, is intended to reverse the negative effects of cannabinoid overdose within 1 hour of administration. The signs and symptoms of cannabinoid overdose range from profound sedation to anxiety and panic to psychosis with hallucinations.


Show ANEB Financials

Consumer Interest
SEC Filings

Recent trades of ANEB by members of U.S. Congress

Quiver Logo

No Congress Trading data for this ticker

Congress Trading Dashboard

Recently reported changes by institutional investors

Quarterly net insider trading by ANEB's directors and management

Quiver Logo

No recent Insider Trading for this ticker

Insider Trading Dashboard

Government lobbying spending instances

Quiver Logo

No Corporate Lobbying instances for this ticker

Corporate Lobbying Dashboard
U.S. Patents

New patents grants

  • Patent Title: Formulations and methods for treating acute cannabinoid overdose Oct. 12, 2021
Government Contracts

Federal grants, loans, and purchases

Quiver Logo

No Government Contracts for this ticker

Government Contracts Dashboard

Number of mentions of ANEB in WallStreetBets Daily Discussion


Recent insights relating to ANEB

CNBC Recommendations

Recent picks made for ANEB stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in ANEB

Corporate Flights

Flights by private jets registered to ANEB